Navigation Links
daclizumab in Medical News

Transplanted heart made more acceptable by daclizumab

Daclizumab has been found to reduce the risk of cellular rejection after a heart transplant// when used on top of standard immunosuppression. The drug, a humanized monoclonal antibody, is directed against the interleukin-2 receptor, thereby inhibiting T-cell proliferation. Patients who we...

Renal Transplantation in Children Younger Than 6 Years Old

...us in 39%, mycophenolate in 49% and azathioprine in 51%. A steroid-free protocol was used in 17% of the patients. In the last 21 cases, basiliximab or daclizumab was added. The group found that there were 13 (32.5%) graft losses. Four of these had artery/vein thromboses, 3 chronic rejections, 3 deaths, an...
daclizumab in Medical Technology

Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients With Relapsing Multiple Sclerosis

- Anti-IL-2 receptor antibody significantly reduced the number of new or enlarged lesions compared to placebo; data to be submitted for presentation at upcoming medical meeting - CAMBRIDGE, Mass. and FREMONT, Calif., March 12, 2007 /PRNewswire-FirstCall/ -- Biogen Idec, Inc. and PDL BioPharma, Inc...
daclizumab in Biological Technology

Phase 2 Data Show Daclizumab Significantly Reduced Multiple Sclerosis Lesions in Patients Receiving Interferon Beta Therapy

- Phase 2 monotherapy trial to be initiated by end of 2007 - PRAGUE, Czech Republic, Oct. 11 /PRNewswire-FirstCall/ -- Biogen Idec Inc. (Nasdaq: BIIB ) and PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ) announced today that Phase 2 data demonstrated a significant reduction in new or enlarge...

Astellas Receives FDA Approval for Use of Prograf(R) (Tacrolimus) in Conjunction With Mycophenolate Mofetil (MMF) in Kidney Transplant Recipients

...y transplant recipients. The trial randomly assigned 1,589 kidney transplant recipients to receive standard dose CyA, MMF and corticosteroids (CS); or daclizumab induction, MMF and corticosteroids in combination with low-dose CyA, Prograf or sirolimus (Siro). The primary endpoint of the study was renal function...

PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development

...HuLuc63 in multiple myeloma, PDL 192 in preclinical development and several additional research stage candidates. PDL's immunological programs include daclizumab in multiple sclerosis and other indications, visilizumab in various potential indications and several preclinical candidates. The company is planning ...
Other Tags
(Date:7/29/2015)... ... July 29, 2015 , ... In ... help with the problems of substance abuse that face today’s society, A Forever ... to come to their rehabilitation center. The facility, located in Southwest Michigan hosted ...
(Date:7/29/2015)... ... July 29, 2015 , ... This past week, CARE Surrogacy Center ... a treasured member of the CARE extended family. , By shedding light on ... parents across the globe gain a newfound perspective on surrogacy in Mexico. The center ...
(Date:7/29/2015)... ... July 29, 2015 , ... Abt Associates has named Selena ... division. In her position, Ramkeesoon will help build and expand work in ... spent close to a decade at ICF International, most recently as a vice ...
(Date:7/29/2015)... Boston, MA (PRWEB) , ... July 29, 2015 ... ... nonconforming experience widespread discrimination and health inequities. Since 2012, Massachusetts law has provided ... public education, and business. However, the law does not protect against discrimination based ...
(Date:7/29/2015)... , ... July 29, 2015 , ... " Core Organizer ... look at the latest and coolest applications on the market for iOS, Android, and ... and shared with viewers how this app will help anyone get organized. , Wouldn’t ...
Breaking Medicine News(10 mins):Health News:MADD Victim Services Specialist Visits A Forever Recovery Rehabilitation Facility 2Health News:Heartfelt Interview Shows Extraordinary Impact of CARE Surrogacy Center Mexico 2Health News:Heartfelt Interview Shows Extraordinary Impact of CARE Surrogacy Center Mexico 3Health News:Selena Ramkeesoon Joins Abt Associates as Vice President for Strategic Communications 2Health News:Fenway Health Researcher: Legal Protections in Public Settings are a Critical Public Health Issue for Transgender and Gender-Nonconforming People 2Health News:Fenway Health Researcher: Legal Protections in Public Settings are a Critical Public Health Issue for Transgender and Gender-Nonconforming People 3Health News:Get More Organized with the Core Organizer App 2
(Date:7/8/2015)... NEW YORK , July 8, 2015  BD ... announced BD & Guidepoint Mentor, a new ... to Guidepoint,s expert network services. BD ... technologies to improve healthcare delivery and outcomes and, with ... start-up entrepreneur will be able to directly engage with ...
(Date:7/7/2015)... -- Research and Markets ( ... "Capacitive Fingerprint Sensors Patent Landscape" report ... fingerprint sensing technology is the most reliable and ... developed. This patent landscape focuses on fingerprint sensors ... of capacitive fingerprint sensors is closely linked to ...
(Date:7/2/2015)... , June 25, 2015 ... the addition of the "Natural Language Processing ... (Recognition, IVR, OCR, Pattern & Image Recognition) - ... offering. The key vendors occupying the ... IBM Corporation, Microsoft Corporation, NetBase Solutions, SAS Institute ...
Breaking Biology News(10 mins):BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2
Other Contents